779 results on '"Cirrosis hepatica"'
Search Results
2. Cardiomiopatía cirrótica – ¿Realidad clínica o simple curiosidad académica? Revisión.
- Author
-
Hugo Ramos and Mario Altieri
- Subjects
cirrosis hepática ,cardiomiopatía ,tratamiento ,trasplante hepático ,Medicine ,Medicine (General) ,R5-920 - Abstract
El tratamiento de la enfermedad hepática terminal con Cardiomiopatía Cirrótica (CMC) es el trasplante hepático (TH), sin embargo el tratamiento médico con la combinación de diuréticos y beta bloqueantes no selectivos antes y después tienen un rol importante. A diferencia de la insuficiencia cardíaca de otras etiologías, los inhibidores de la enzima convertidora (IECA), los bloqueadores del receptor de angiotensina 2 (ARA-2) o los inhibidores del receptor de angiotensina y de neprilisina (ARNI) no se recomiendan debido a la fisiopatología particular de la CMC. El shunt porto-sistémico intrahepático transyugular (Transjugular intrahepatic porto-systemic shunt: TIPS) tiene sus indicaciones con posibles beneficios y riesgos pero más estudios son necesarios en la CMC. El TH es la opción más eficaz y puede revertir el QTc del ECG y la disfunción diastólica y sistólica; en las últimas décadas, a pesar del aumento de la complejidad en los pacientes (mayor score MELD), con la mejoría de la técnica quirúrgica, cuidados intensivos, drogas inmunosupresoras y diagnóstico por imágenes la sobrevida ha mejorado significativamente.
- Published
- 2024
- Full Text
- View/download PDF
3. Criterios de Baveno VII para la exclusión de várices esofágicas en una población peruana: estudio transversal.
- Author
-
Campoverde-Cueva, Celide, Celedonio-Campos, Williams, Campos-Salazar, Brayan, Zambrano-Huailla, Rommel, Alejandra Vizcarra-Zevallos, Karla, and Garavito-Rentería., Jorge
- Abstract
Introduction: Esophageal varices represent one of the main complications in patients with liver cirrhosis. The main objective was to determine the diagnostic performance of the new Baveno VII criteria to exclude the presence of esophageal varices in compensated advanced chronic liver disease (cACLD), in an independent Peruvian population. Materials and methods: A cross-sectional study, including patients with cACLD, upper digestive endoscopy, and transient hepatic elastography from January 2017 to December 2019. Results: The mean age was 59.4 (12.9) years, while the mean measurement of liver stiffness was 27.21 (14.6) kPa. The prevalence of esophageal varices was 85.6%; non-alcoholic fatty liver disease (NAFLD) (63.6%) was the most prevalent etiology, followed by viral hepatitis (14.4%). For esophageal varices exclusion, Baveno VII criteria for all etiologies demonstrated adequate sensitivity and negative predictive value (sensitivity: 96.7%; 95% confidence interval [CI]: 92.3%-98.8%; negative predictive value: 76.9%, 95% CI: 56.4% -91%). However, better diagnostic performance was found when applying the Baveno VII criteria without considering NAFLD patients (sensitivity: 98.4%, 95% CI: 79.2% -99.2%; negative predictive value: 90.9%, 95% CI: 79.2% -99.2%). This would prevent 14% of endoscopic studies with a 9% risk of failing to detect esophageal varices. Conclusions: The Baveno VII criteria present good diagnostic performance for the exclusion of esophageal varices, especially in patients with cACLD without NAFLD, in an independent Peruvian population. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
4. Anormalidades hematológicas en enfermedad hepática, fisiopatología y consideraciones terapéuticas.
- Author
-
Hernández Ángeles, Yossadara, Gallardo Rodríguez, Adán Germán, Moreno 3;, Emmanuel Martínez, and Ramos Peñafiel, Christian
- Abstract
Alterations in blood cell counts are the most prominent and recurrent clinical findings among patients suffering from both acute and chronic liver disease. These changes are an important marker of liver failure and often play a key role in the evaluation and management of these patients. Together with the prolongation of coagulation tests, thrombocytopenia is the most common disorder among these individuals. This condition, as well as leukopenia, is largely attributable to hypersplenism, a disorder in which the spleen retains and destroys blood cells, including platelets. However, when the platelet count drops below 10x103/µl, it is essential to consider other causes, such as autoimmune factors that may be contributing to the development of thrombocytopenia. Anemia, defined as a decrease in red blood cell count or hemoglobin levels, is another common characteristic of liver disease. Although in most cases macrocytic anemia occurs, in some situations it can be secondary to hemolytic events, as observed in Zieve's syndrome. This wide range of manifestations of anemia among liver patients highlights the complex interaction between liver and blood components. Despite advances in understanding the underlying causes of these cytopenias, treatment options remain limited. Therapeutic options generally focus on the transfusion of blood products to compensate for deficiencies in cell counts or on the use of thrombopoietin (TPO) analogues to temporarily stimulate platelet production in the bone marrow. However, these treatments tend to address the symptoms rather than the root causes of hematologic disorders in liver disease. The persistence and worsening of these disorders may serve as early indicators of the progression of liver failure. The complicated relationship between liver and hematological homeostasis remains the subject of research. A deeper understanding of these mechanisms could potentially open the door toward more targeted and effective therapeutic approaches to address cytopenias in the context of liver disease. [ABSTRACT FROM AUTHOR]
- Published
- 2024
- Full Text
- View/download PDF
5. Management of refractory hepatic hydrothorax: a report of two cases and review of the literature.
- Author
-
Calixto-Aguilar, Lesly and Díaz Ferrer, Javier
- Subjects
HYDROTHORAX ,CIRRHOSIS of the liver ,DYSPNEA ,PLEURODESIS ,DIURETICS - Abstract
Copyright of Revista de Gastroenterología del Perú is the property of Sociedad de Gastroenterologia del Peru and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2024
- Full Text
- View/download PDF
6. VALORACIÓN GLOBAL SUBJETIVA Y LA EVALUACIÓN GLOBAL ROYAL FREE HOSPITAL EN ENFERMEDAD HEPÁTICA CRÓNICA.
- Author
-
Valero Cubillán, Paola María, Cecilia Daza, Mareidys, Barboza Zambrano, Hazel, and Anderson Vásquez, Hazel
- Subjects
RESEARCH ,NUTRITIONAL assessment ,CONFIDENCE intervals ,CHRONIC diseases ,CROSS-sectional method ,LIVER diseases ,MALNUTRITION ,DESCRIPTIVE statistics ,STATISTICAL correlation ,STATISTICAL sampling ,SENSITIVITY & specificity (Statistics) ,DATA analysis software ,NUTRITIONAL status ,ALGORITHMS - Abstract
Copyright of Enfermería Investiga: Investigaciin, Vinculación, Docencia y Gestiin is the property of Revista Enfermeria Investiga and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2024
- Full Text
- View/download PDF
7. Characterization of patients with acutely decompensated cirrhosis who received care in different highly complex emergency services of Medellín, Colombia.
- Author
-
Vélez, Juan Luis, Pérez, Andrea, Blanco, Juan David, Berrouet, Marie Claire, Valencia, Lorena, Soto, Sofía, Ramírez, Ana Sofía, Martínez, Víctor, Gallego, Juan Luis, and Jaillier, Julia
- Abstract
Copyright of Biomédica: Revista del Instituto Nacional de Salud is the property of Instituto Nacional de Salud of Colombia and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2023
- Full Text
- View/download PDF
8. Albúmina humana: indicaciones basadas en la evidencia.
- Author
-
Garnica Camacho, César Enrique
- Abstract
Albumin is the most abundant circulating protein in the body and its clinical importance has been unraveled over time. Since 1940 it has been used in different clinical scenarios. Its protective properties of the microvasculature and the glycocalyx are those that are considered when treating patients with endothelial damage (hypovolaemia, sepsis, burns); however, there are no detailed indications for its use. This review will break down accepted indications and suggest protocols for conscientious use. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
9. La carga de la enfermedad por cirrosis hepática en México.
- Author
-
Flores-García, Nayelli C., Dirac, Mae, Han, Hannah, and Kershenobich-Stalnikowitz, David
- Abstract
Copyright of Gaceta Médica de México is the property of Publicidad Permanyer SLU and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2023
- Full Text
- View/download PDF
10. Anormalidades hematológicas en enfermedad hepática, fisiopatología y consideraciones terapéuticas
- Author
-
Yossadara Hernández Ángeles, Adán Germán Gallardo Rodríguez, Emmanuel Martínez Moreno, and Christian Ramos Peñafiel
- Subjects
cirrosis hepática ,trombocitopenia ,leucopenia ,anemia ,médula ósea ,hiperesplenismo ,Medicine - Abstract
Las alteraciones en los recuentos celulares sanguíneos representan los hallazgos clínicos más notorios y recurrentes en pacientes que padecen enfermedad hepática, tanto aguda como crónica. Estos cambios constituyen un marcador importante de la disfunción hepática y, a menudo, desempeñan un papel crucial en la evaluación y manejo de estos pacientes. En conjunto con el alargamiento de las pruebas de coagulación, la trombocitopenia es la irregularidad más prevalente en estos individuos. Esta condición, así como las leucopenias, se le atribuye en gran medida al hiperesplenismo, una alteración en la que el bazo retiene y destruye las células sanguíneas, incluidas las plaquetas. Sin embargo, cuando el conteo plaquetario desciende por debajo de 10 x 103/µl, es fundamental considerar otras causas, como factores autoinmunitarios que pueden estar contribuyendo con la trombocitopenia. La anemia, definida como una disminución en el número de glóbulos rojos o en los niveles de hemoglobina, es otra característica constante que acompaña a la enfermedad hepática. Aunque en la mayoría de los casos la anemia es macrocítica, en algunas situaciones puede ser secundaria a eventos hemolíticos, como lo observado en el síndrome de Zieve. Esta diversidad en las manifestaciones de la anemia en pacientes hepáticos subraya la complejidad de las interacciones entre el hígado y los componentes sanguíneos. A pesar de los avances en la comprensión de las causas subyacentes de estas citopenias, las opciones del tratamiento siguen siendo limitadas. Generalmente, las opciones terapéuticas se enfocan en la administración de transfusiones de hemocomponentes para compensar las deficiencias en los recuentos celulares o en el uso de análogos de trombopoyetina (TPO) para estimular temporalmente la producción de las plaquetas en la medula ósea. No obstante, estos tratamientos tienden a abordar los síntomas más que las causas fundamentales de las alteraciones hematológicas en la enfermedad hepática. La persistencia y el empeoramiento de estas alteraciones pueden servir como indicadores tempranos de la progresión de la disfunción hepática. La relación intrincada entre el hígado y la homeostasis hematológica continúa siendo objeto de investigación, la compresión más profunda de estos mecanismos podría abrir potencialmente la puerta hacia enfoques terapéuticos más específicos y efectivos para abordar las citopenias en el contexto de la enfermedad hepática.
- Published
- 2024
- Full Text
- View/download PDF
11. Tabla de la normalidad de las pruebas psicométricas para el diagnóstico de encefalopatía hepática subclínica en la población dominicana
- Author
-
Sterling Féliz, Matilde Peguero, Gabriela García Segura, Luis Pérez Méndez, Norma Marlene Pérez, Kenia Torres, and Lucia Bayona
- Subjects
Encefalopatía hepática ,encefalopatía subclínica ,test psicométricos ,diagnósticos encefalopatía ,cirrosis hepática ,psicometría ,Medicine (General) ,R5-920 ,Public aspects of medicine ,RA1-1270 - Abstract
Introducción: La encefalopatía hepática mínima (EHM), es una enfermedad definida por la existencia de varias alteraciones neurofisiológicas, indetectables a la exploración neurológica y el examen clínico. Dentro de las estrategias diagnosticas para la EHM se contemplan las pruebas psicométricas (PHE), pero para su aplicación es indispensable la estandarización previamente en la población de estudio. Objetivo: El estudio se propuso determinar la tabla de la normalidad de las PHE para diagnosticar la encefalopatía hepática subclínica en una muestra de la población dominicana. Método: Se realizó un estudio descriptivo, prospectivo y transversal en un hospital de referencia nacional. Se analizaron 134 personas clasificados por grupos de edades (18-70 años de edad) y años de escolaridad. Se diseñó una tabla de 5x5. Se estudió la influencia de la edad, sexo, uso de espejuelo y de los años de escolarización en el rendimiento de cada uno de las PHE, para lo cual se utilizaron las siguientes pruebas estadísticas: análisis de varianza (ANOVA), prueba t de Student y regresión lineal. Resultado: La escolaridad y la edad fueron variables determinantes en el desempeño de las 5 pruebas psicométricas. Pero, la correlación univariable de la edad con el desempeño de la prueba TMS no hubo diferencias intra e inter grupos estadísticamente significativas (p>0.171). Conclusión: se confecciono la fórmula de predicción de resultados de los test psicométricos. Ninguno sobrepasó el punto de corte de la puntuación que oscila entre los -4 y los +2 puntos.
- Published
- 2024
- Full Text
- View/download PDF
12. Fecal calprotectin level as a marker of esophageal varices in Egyptian HCV cirrhotic patients
- Author
-
D.A. Header, W.I. Ellakany, and A.I. Ellakany
- Subjects
Calprotectinafecal ,Várices esofágicas ,Cirrosis hepática ,Diseases of the digestive system. Gastroenterology ,RC799-869 - Abstract
Introduction and aim: Esophageal varices are one of the complications of portal hypertension in cirrhotic patients that lead to high morbidity and mortality. Our aim was to assess the fecal calprotectin (FC) level in Egyptian cirrhotic patients as a non-invasive marker for the presence of esophageal varices. Materials and methods: The current study included 250 participants in the period from June 2019 to November 2020, divided into three groups: group 1: 100 HCV cirrhotic patients with esophageal varices that would then be subdivided, according to the Paquet classification; group 2: 100 HCV cirrhotic patients without esophageal varices; group 3: 50 normal age and sex-matched healthy subjects as the control group. Patients with other causes of abnormal calprotectin results were excluded. Results: The comparison of FC in the three study groups revealed a statistically significant difference, with FC levels higher in groups 1 and 2 (mean 66.4 ± 10.41 and 48.4 ± 10.92, respectively). There was a significant difference in FC levels between the subgroups, subdivided according to the Paquet classification (P = .001). FC levels were higher in the grade III and IV subgroups. FC in the diagnosis of HCV cirrhotic patients with esophageal varices showed the best performance when the cut-off value was >55; AUC was 0.918, with 92% sensitivity, 95% specificity, and 93% accuracy. Conclusion: FC levels serve as a screening tool for esophageal varices. FC was higher in cirrhotic patients with esophageal varices, especially in the grade III and IV subgroups, according to the Paquet classification. Resumen: Introducción y objetivo: Las várices esofágicas son una de las complicaciones de la hipertensión portal en pacientes cirróticos, lo cual lleva a una alta morbilidad y mortalidad. Nuestro objetivo fue evaluar el nivel de calprotectina fecal (CF) en pacientes cirróticos egipcios como marcador no invasivo de la presencia de várices esofágicas. Materiales y métodos: El presente estudio incluyó a 250 participantes en el período de junio de 2019 a noviembre de 2020, divididos en tres grupos: grupo 1: 100 pacientes cirróticos por VHC con várices esofágicas, posteriormente subdivididos según la clasificación de Paquet; grupo 2: 100 pacientes cirróticos por VHC sin várices esofágicas; grupo 3: 50 sujetos sanos emparejados por edad y sexo como grupo de control. Se excluyó a pacientes con otras causas de calprotectina anormal. Resultados: La comparación entre los tres grupos estudiados en cuanto a CF reveló una diferencia estadísticamente significativa. Los niveles de CF fueron mayores en los grupos 1 y 2, con medias de 66.4 ± 10.41 y 48.4 ± 10.92, respectivamente. Existió una diferencia significativa en los niveles de CF entre los subgrupos, subdivididos según la clasificación de Paquet (P = .001). Los niveles de CF fueron más altos en los subgrupos de grado III y IV. La CF en el diagnóstico de pacientes cirróticos por VHC con várices esofágicas mostró el mejor desempeño cuando el punto de corte fue > 55; el área bajo la curva (AUC) fue 0.918, con 92% de sensibilidad, 95% de especificidad y 93% de precisión. Conclusión: Los niveles de CF sirven como herramienta de tamizaje para várices esofágicas. La CF fue mayor en pacientes cirróticos con várices esofágicas, especialmente en los subgrupos de grado III y IV, según la clasificación de Paquet.
- Published
- 2023
- Full Text
- View/download PDF
13. La sobreexpresión de FoxO1 en el hígado esta positivamente asociada al grado de daño hepático en pacientes cirróticos
- Author
-
Fernández-Galán Esther, Sandalinas Silvia, Macias-Muñoz Laura, Portolés Irene, Ribera Jordi, Morales-Romero Blai, Pauta Montse, Casals Gregori, Boix Loreto, Jiménez Wladimiro, and Morales-Ruiz Manuel
- Subjects
akt ,cirrosis hepática ,enfermedad hepática crónica ,foxo1 ,regeneración hepática ,Medical technology ,R855-855.5 - Abstract
La enfermedad hepática crónica y sus complicaciones, la cirrosis y el carcinoma hepatocelular, presentan una elevada mortalidad. Los tratamientos curativos, como la hepatectomía parcial o el trasplante hepático, tienen una aplicación limitada en pacientes con cirrosis, por su escasa capacidad de regeneración hepática. Son necesarias otras alternativas diagnósticas y terapéuticas para prevenir la progresión de la enfermedad y mejorar la supervivencia. Diversos estudios preclínicos demuestran el importante papel de la proteína quinasa B(Akt) en la disfunción hepática, aunque aún se desconoce el estado de Akt y sus dianas en las patologías hepáticas crónicas. El principal objetivo es determinar el estado de activación de la vía Akt y su relación con la función hepática en pacientes cirróticos.
- Published
- 2023
- Full Text
- View/download PDF
14. Factores de riesgo de fibrosis avanzada en enfermedad hepática esteatósica asociada a disfunción metabólica en pacientes con diabetes mellitus 2.
- Author
-
Miranda Manrique, Gonzalo and Vildózola Gonzales, Herman
- Abstract
Copyright of Revista de Gastroenterología del Perú is the property of Sociedad de Gastroenterologia del Peru and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2023
- Full Text
- View/download PDF
15. Factores de riesgo para fibrosis hepática en pacientes diabéticos con enfermedad renal crónica terminal.
- Author
-
Yepes-Barreto, Ismael, Romero, Diana, and Coronado-Daza, Jorge
- Abstract
Introduction: Liver cirrhosis is the fourth cause of death in the world. Fatty liver disease is the most common cause of chronic liver disease (CKD) in most countries. Identifying risk factors for liver fibrosis in a population with end-stage renal disease (ESRD) may facilitate early diagnosis of this complication and allow the activation of follow-up protocols to reduce morbidity and mortality in these patients. Materials and methods: A cross-sectional and analytical study was carried out. Patients on hemodialysis, older than 18 years with a diagnosis of diabetes mellitus and ESRD were included. The hypotheses were contrasted through the chi-square test and Student's T-test, as appropriate. Statistical significance was established at a p-value = 0.05. Results: A prevalence of significant liver fibrosis and cirrhosis of 17% was found. Factors associated with liver fibrosis were a history of cerebrovascular disease, peripheral vascular disease, body mass index (BMI), total cholesterol, glycosylated hemoglobin, sodium, and aspartate aminotransferase (AST). No relationship was observed between the NAFLD (non-alcoholic fatty liver disease) score, the APRI index (AST to Platelet Ratio Index), and fibrosis. Conclusion: The prevalence of significant liver fibrosis in patients with diabetes and ESRD is similar to that reported in other populations of patients with diabetes. However, some factors, such as BMI, could behave differently and favor the appearance of liver injury with lower degrees of obesity than previously reported in the literature. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
16. Enfermedad hepática en Colombia: estimación de la carga económica y de enfermedad.
- Author
-
Fernanda Bejarano-Ramírez, Diana, José Alvis-Zakzuk, Nelson, Carrasquilla, Gabriel, Porras-Ramírez, Alexandra, and Vera-Torres, Alonso
- Abstract
Introduction: Liver diseases have a significant impact on global morbidity and mortality rates, primarily attributed to cirrhosis and hepatocellular carcinoma. However, the true extent of their impact on patients, healthcare systems, and countries is often underestimated. Materials and methods: This descriptive, cross-sectional study aimed to determine the economic burden associated with premature deaths caused by cirrhosis and primary liver cancer. The economic assessment was conducted by analyzing potentially productive years of life lost (PPYLL) due to liver diseases in Colombia between 2009 and 2016. Results and conclusions: The total burden of liver disease accounted for 687,861 disability-adjusted life years (DALYs). Men experienced a higher number of years of life lost from mortality (YLL), while women had a greater number of years lived with a disability (YLD). The economic burden of deaths caused by cirrhosis and primary liver cancer exceeded USD 8.6 million, highlighting the urgency to enhance intervention strategies ranging from promotion and prevention to timely diagnosis and treatment. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
17. Liver Cirrhosis Patient with Complications of Hepatic Hydrothorax. Case Report.
- Author
-
Vidyani, Amie, Sugihartono, Titong, Widodo, Budi, Purbayu, Herry, Maimunah, Ummi, kholili, Ulfa, Thamrin, Husin, Miftahussurur, Muhammad, Abbas Nussi, Iswan, and Setiawan, Poernomo Boedi
- Subjects
CIRRHOSIS of the liver ,HEPATIC echinococcosis ,PATIENT experience ,ASCITES ,DYSPNEA ,HYDROTHORAX ,SURVIVAL rate ,COMPUTED tomography ,PLEURAL effusions - Abstract
Copyright of Gaceta Médica de Caracas is the property of Academia Nacional de Medicina and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2023
- Full Text
- View/download PDF
18. Comparación de distintas herramientas para la evaluación de la malnutrición y la sarcopenia en pacientes con cirrosis hepática.
- Author
-
Manuel Aldana-Ledesma, Juan, Vázquez-Rodríguez, Daniela, Lazcano-Becerra, Montserrat, Santino García-Jiménez, Edgar, Karen Tapia-Calderón, Diana, Ángel Ibarra-Estrada, Miguel, Félix Téllez, Francisco Alejandro, and Velarde-Ruiz Velasco, José Antonio
- Subjects
- *
GRIP strength , *CONVENIENCE sampling (Statistics) , *ARM muscles , *CIRRHOSIS of the liver , *ARM circumference , *BODY mass index - Abstract
Introduction: malnutrition and sarcopenia are frequent in the population with liver cirrhosis and have a negative impact on the performance status and life expectancy of these patients. There are multiple assessment tools for malnutrition and sarcopenia in cirrhosis. Some of these tools are reproducible and easy to apply, which facilitates their global application for screening malnutrition and sarcopenia. Objective: to assess malnutrition and sarcopenia in liver cirrhosis and to compare the accuracy of diagnostic tools in this population. Method: a cross-sectional analytical study was conducted with convenience sampling by using continuous inclusion of patients with liver cirrhosis in a tertiary care center during December 2018 to May 2019. The nutritional assessment was carried out with arm anthropometry, body mass index (BMI), and the algorithm of the Royal Free Hospital Subjective Global Assessment (RFH-SGA). For the evaluation of sarcopenia, the hand grip strength test with a hand dynamometer was applied. The results were reported in measures of central tendency expressed in frequency and percentage. A Kendall's Tau-b rank correlation coefficient was performed with non-parametric variables, considering a p < 0.05 as a statistically significant value. Results: a total of 103 patients were included with a predominance of the male gender (79.6 %) and a mean age of 51 years (± 10). The etiology of liver cirrhosis corresponded more frequently to alcohol consumption (68 %) and most of the patients were Child-Pugh C (57.3 %) with a mean MELD of 21.9 (± 8.9). A mean BMI with dry weight of 25.2 kg/m2 was reported, and with respect to the WHO classification by BMI, 7.8 % were underweight and 59.2 % were malnourished by RFH-SGA. Sarcopenia was present in 88.3 % using the hand grip strength test, for which a mean of 18.99 kg was found. A Kendall's Tau-b rank correlation coefficient was performed between BMI and RFH-SGA, which showed no statistically significant association, as well as between mean arm muscle circumference percentiles and hand grip strength. Conclusions: global assessment in liver cirrhosis should include screening for malnutrition and sarcopenia, for which validated, accessible and safe application tools should be used, such as anthropometric assessment, RFH-SGA, and hand grip strength. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
19. Enfermedad hepática en Colombia: estimación de la carga económica y de enfermedad
- Author
-
Diana Fernanda Bejarano Ramirez, Nelson José Alvis Zakzuk, Gabriel Carrasquilla Gutiérrez, Alexandra Porras Ramírez, and Alonso Vera Torres
- Subjects
Carga económica ,años de vida saludable perdidos ajustados por discapacidad ,años de vida perdidos por muerte prematura ,años vividos con discapacidad ,cirrosis hepática ,neoplasias hepáticas ,Diseases of the digestive system. Gastroenterology ,RC799-869 - Abstract
Introducción: la enfermedad hepática representa una de las principales causas de morbimortalidad a nivel mundial, principalmente por cirrosis y hepatocarcinoma; sin embargo, se subestima su impacto para el paciente, sistema de salud y el país. Materiales y métodos: estudio descriptivo de corte transversal que determinó la carga económica asociada a las muertes prematuras por cirrosis y tumores primarios del hígado, mediante la valoración económica de los años productivos de vida potencialmente perdidos (APVPP) en Colombia y de enfermedad hepática en Colombia entre 2009 y 2016. Resultados y conclusiones: la carga total de enfermedad hepática representó 687,861 años de vida saludable perdidos ajustados por discapacidad (AVAD), los hombres con mayores años de vida perdidos por muerte prematura (APMP) y las mujeres con mayores años vividos con discapacidad (AVD). Las muertes por cirrosis y tumores primarios del hígado representan una carga económica que supera los 8,6 millones de dólares, lo cual refleja la necesidad de fortalecer las estrategias de intervención desde la promoción y prevención hasta el diagnóstico y tratamiento oportuno.
- Published
- 2023
- Full Text
- View/download PDF
20. Degeneración hepatocerebral adquirida: una rara complicación neurológica de la cirrosis hepática
- Author
-
Catarina Medeiros and Rita Serras Jorge
- Subjects
degeneración hepatocerebral ,cirrosis hepática ,manganeso ,Medicine ,Internal medicine ,RC31-1245 - Abstract
Liver cirrhosis is a major cause of morbidity and mortality worldwide. It should be considered a multisystemic disease. Various neurological complications are associated with cirrhosis. We reported a 64-years-old woman with medical history of hepatic cirrhosis caused by Hepatitis B and Hepatitis C virus, Child-Pugh Score 8 (Class B), with portal hypertension, ascites suppressed with diuretics, esophageal varices and hypertensive gastropathy, that presents with seven months history of subacute-onset hand tremor and postural imbalance. Neurological examination showed bilateral extreme nystagmus, rest and kinetic hand tremor, doubtful Romberg test and slightly enlarged base gait. Dosage of ammonia was normal. MRI showed homogenously increased T1 signal within the basal ganglia (nucleus pallidus), with normal T2-weighted, associated to manganese accumulation. The diagnose of Acquired hepatocerebral degeneration was made. Acquired hepatocerebral degeneration is a rare and debilitating neurological syndrome, characterized by movement disorders and cognitive impairment in cirrhosis or portosystemic shunts. Bilateral hyperintensity in the globus pallidus on T1-weighted sequences, with normal T2-weighted are the most common abnormal finding. It is a consequence of manganese deposition in nucleus ganglia. Medical treatments are not effective. Liver transplantation showed good outcomes.
- Published
- 2023
- Full Text
- View/download PDF
21. VALORACIÓN ANTROPOMÉTRICA: SU ROL EN EL DIAGNÓSTICO NUTRICIONAL EN PACIENTES CON CIRROSIS HEPÁTICA.
- Author
-
Anderson Vásquez, Hazel and González, Luisandra
- Abstract
Copyright of Enfermería Investiga: Investigaciin, Vinculación, Docencia y Gestiin is the property of Revista Enfermeria Investiga and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2023
- Full Text
- View/download PDF
22. Ascitis: fisiopatología, diagnóstico y tratamiento.
- Author
-
Vidal-González, David, Moreno-Madrigal, Luis Guillermo, Pérez-López, Karla Paola, and Vera-Nungaray, Saúl André
- Abstract
Ascites is the accumulation of fluid in the peritoneal cavity, caused by a wide variety of entities, the most common is liver cirrhosis. In these patients, the development of ascites is the consequence of splanchnic vasodilation, a decrease in the effective circulating volume and activation of the sympathetic nervous system and the renin angiotensin-aldosterone system, in addition to a systemic inflammatory process. The diagnostic approach includes, in addition to clinical data suggestive of ascites and its specific causes, imaging studies (abdominal ultrasound is the initial method of choice, and can be complemented with tomography or magnetic resonance imaging) and laboratory studies, such as the serum-ascitic albumin gradient (which allows the distinction between causes related to portal hypertension versus oncological, infectious and other inflammatory ones, nephrotic syndrome, etc.), stains, cultures and cytology, among others. Some molecular biomarkers are under investigation. Management is diverse and depends on the specific cause. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
23. Giant Hepatocellular Carcinoma in Cirrhotic Liver. Case Report and Literature Review
- Author
-
Jorge Luis Montes de Oca Mastrapa, Johnny Pérez Betancourt, and Alejandro Cisneros Carmenate
- Subjects
carcinoma hepatocelular ,cirrosis hepática ,reporte de casos ,Internal medicine ,RC31-1245 ,Special situations and conditions ,RC952-1245 - Abstract
Hepatocellular carcinoma is the most common primary liver neoplasm. It is the sixth most common tumor in the world, between 500,000 and one million cases diagnosed each year, and is the second most common cause of death from cancer. The disease develops almost exclusively in patients with underlying chronic liver disease, 85 to 95 % of who have developed cirrhosis. Surgical treatment, resection or liver transplant, continues to be the choice. The case of a 55-years-old male patient with a history of health with symptoms of gastric fullness, hematemesis or melena is presented. Physical examination revealed a tumor of more than 16 centimeters palpable in the epigastrium. By abdominal ultrasonography and simple and contrasted tomography, the initial diagnosis was made of a giant hepatocellular carcinoma of more than 16 centimeters in segments II and III. Surgical resection of the tumor was performed, confirming by the anatomopathological study a well-differentiated hepatocellular carcinoma with cirrhotic liver. After 6 months of surgery, favorable clinical and tomographic evolution was confirmed. Hepatocellular carcinoma continues to be a rare entity for which surgical resection is a therapeutic option. An atypical case diagnosed and operated on for giant hepatocellular carcinoma with a cirrhotic liver is presented.
- Published
- 2022
24. Factores asociados a la masa y la fuerza muscular en pacientes con cirrosis hepática: un estudio transversal
- Author
-
Juan David Vélez Aguirre and Ismael de Jesús Yepez Barreto
- Subjects
Sarcopenia ,Cirrosis hepática ,Evaluación nutricional ,Fuerza muscular ,Diseases of the digestive system. Gastroenterology ,RC799-869 - Abstract
Introducción: la sarcopenia es una complicación frecuente de cirrosis y se ha relacionado con progresión de insuficiencia hepática y aumento de las complicaciones, incluida la mortalidad. El objetivo del presente estudió fue determinar los factores asociados a la masa y la fuerza muscular en pacientes cirróticos. Métodos: estudio de corte transversal, descriptivo y analítico. Se incluyó a todos los adultos que acudieron a valoración ambulatoria por hepatología con diagnóstico de cirrosis hepática. A todos se les realizó una valoración nutricional que incluyó mediciones antropométricas, bioimpedanciometría, fuerza de agarre y la escala de tamización Royal Free Hospital-Nutritional Prioritizing Tool (RFH-NPT). Se realizó un análisis de regresión lineal o logística, según correspondiera. Resultados: se incluyó a 40 pacientes. La frecuencia de malnutrición fue de 17,5% de acuerdo con la fuerza de agarre. Los principales determinantes de la masa muscular en el análisis lineal multivariable fueron la edad, el valor de proteína corporal total y el agua corporal total. La fuerza de agarre también fue un predictor significativo en la regresión lineal univariable. Las variables relacionadas con fuerza muscular disminuida fueron el puntaje Child-Pugh, la historia de ascitis y de encefalopatía hepática, el consumo de terapias de disminución de amonio, la puntuación en la escala RFH-NPT y la masa libre de grasa. Conclusiones: la masa muscular esquelética del paciente cirrótico se asoció con la edad, cambios en la composición corporal y la fuerza de agarre. Los determinantes de la fuerza muscular fueron el estadio de la enfermedad, el consumo de terapias de disminución de amonio y la puntuación en la escala RFH-NPT.
- Published
- 2022
- Full Text
- View/download PDF
25. Variables hemodinámicas cardíacas y desenlaces postrasplante hepático en un centro de referencia de trasplantes en Colombia a 2600 metros sobre el nivel del mar
- Author
-
Carlos Mauricio Martínez Montalvo, Laura Catalina Gutierrez, Daniel Valery Rojas, Sandra Valentina Saummet, Camila Sofia Galindo Escucha, Rafael Conde Camacho, and Adriana Varón Puerta
- Subjects
Trasplante de higado ,cirrosis hepatica ,Disfuncion ventricular ,Diseases of the digestive system. Gastroenterology ,RC799-869 - Abstract
Introducción: la valoración hemodinámica mediante ecocardiografía Doppler tiene importancia en la identificación de alteraciones sistólicas/diastólicas como predictor de desenlaces en el postrasplante hepático desde alteraciones cardiovasculares hasta disfunción del injerto y mortalidad. Métodos: estudio de cohorte retrospectivo. Paciente con trasplante hepático en el hospital LaCardio, en Bogotá, Colombia entre enero de 2005 y julio de 2021. Análisis de variables sociodemográficas, comorbilidades, ecocardiografía y variables intraoperatorias con desenlaces primarios como disfunción temprana del injerto, lesión renal aguda (LRA) y mortalidad durante el seguimiento. Se realizó un árbol de clasificación y regresión (CART). Resultados: se analizaron a 397 pacientes, el 54,4% eran hombres, y el 71% tenía algún grado de disfunción diastólica, hipertrofia ventricular izquierda (30,9%) con presencia de disfunción del injerto en el 8% y LRA en el 21%, y una mortalidad del 15% durante el seguimiento del estudio. En el modelo CART para desenlaces de mortalidad y disfunción del injerto se relacionó con la presencia de índice de masa corporal (IMC) < 19 o la combinación de IMC entre 19 y < 24 con diálisis. Conclusión: las variables ecocardiográficas, la sarcopenia y la LRA o requerimiento de terapia de reemplazo renal se relacionan con desenlaces de mortalidad y disfunción del injerto.
- Published
- 2022
- Full Text
- View/download PDF
26. Factores asociados a la masa y la fuerza muscular en pacientes con cirrosis hepática: un estudio transversal.
- Author
-
David Vélez-Aguirre, Juan and de Jesús Yepes-Barreto, Ismael
- Abstract
Introduction: Sarcopenia is a frequent complication of cirrhosis and has been related to the progression of liver failure and increased complications, including mortality. This study aimed to determine the factors associated with muscle mass and strength in cirrhotic patients. Materials and methods: Cross-sectional, descriptive, analytical study. All adults who attended outpatient hepatology assessment with a diagnosis of liver cirrhosis were included. They underwent a nutritional examination that included anthropometric measurements, bioimpedanciometry, grip strength, and the Royal Free Hospital-Nutritional Prioritizing Tool (RFH-NPT) screening scale. A linear or logistic regression analysis was performed as appropriate. Results: 40 patients were included. The frequency of malnutrition was 17.5%, according to grip strength. The main determinants of muscle mass in the multivariate linear analysis were age, total body protein value, and total body water. Grip strength was also a significant predictor in univariate linear regression. Variables related to decreased muscle strength were the Child-Pugh score, history of ascites and hepatic encephalopathy, consumption of ammonium-lowering therapies, RFH-NPT score, and fat-free mass. Conclusions: The skeletal muscle mass of the cirrhotic patient was associated with age, changes in body composition, and grip strength. The muscle strength determinants were the disease's stage, the consumption of ammonium-lowering therapies, and the score on the RFH-NPT scale. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
27. Variables hemodinámicas cardíacas y desenlaces postrasplante hepático en un centro de referencia de trasplantes en Colombia a 2600 metros sobre el nivel del mar.
- Author
-
Mauricio Martínez-Montalvo, Carlos, Catalina Gutiérrez, Laura, Valery Rojas, Daniel, Valentina Saummet, Sandra, Sofía Galindo-Escucha, Camila, Conde-Camacho, Rafael, and Varón, Adriana
- Abstract
Introduction: Hemodynamic assessment by Doppler echocardiography is essential in identifying systolic/diastolic changes as a predictor of outcomes in post-liver transplantation, from cardiovascular changes to graft dysfunction and mortality. Materials and methods: Retrospective cohort study. Patient with a liver transplant at the LaCardio hospital in Bogotá, Colombia, between January 2005 and July 2021. Analysis of sociodemographic variables, comorbidities, echocardiography, and intraoperative variables with primary outcomes such as early graft dysfunction, acute kidney injury (AKI), and mortality during follow-up. A classification and regression tree (CART) was performed. Results: 397 patients were analyzed; 54.4% were men, 71% had some degree of diastolic dysfunction and left ventricular hypertrophy (30.9%) with graft dysfunction in 8% and AKI in 21%, and a mortality of 15% during the study follow-up. In the CART model, mortality and graft dysfunction outcomes were related to a body mass index (BMI) < 19 or a combination of BMI between 19 and < 24 with dialysis. Conclusion: Echocardiographic variables, sarcopenia, AKI, or the requirement for renal replacement therapy are related to mortality and graft dysfunction outcomes. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
28. Cirrosis Hepática en Paciente Masculino de 15 Años Reporte de Caso
- Author
-
Orbe Alvarado, Valeria Fernanda, Sánchez León, Ana Cristhina, Samaniego Samaniego, Ana Cristina, Navas Luna, Alex Xavier, Orbe Alvarado, Valeria Fernanda, Sánchez León, Ana Cristhina, Samaniego Samaniego, Ana Cristina, and Navas Luna, Alex Xavier
- Abstract
Cirrhosis is a chronic, progressive, diffuse and irreversible liver disease caused by multiple causes. It is a common condition that occurs in all latitudes and population groups, is more common after middle age and is predominantly male. Cirrhosis is a major public health problem and a major cause of morbidity and mortality worldwide. It is estimated that 57% of cirrhosis and 78% of primary liver cancers are caused by hepatitis B or C virus infection. Globally, the main causes of cirrhosis are chronic alcohol consumption and chronic viral diseases. Less common causes include autoimmune liver disease, metabolic disease, and nonalcoholic fatty liver disease. Complications of cirrhosis are a serious problem that can cause disability and death in people. A 15-year-old man is reported to report moderate, diffuse, crampy abdominal pain, associated with two episodes of nausea and regurgitation approximately 24 hours after a non-irradiated meal. He also reported an incalculable increase. He was treated with unspecified medications, but his symptoms persisted so he went to the emergency room., La cirrosis es una enfermedad hepática crónica, progresiva, difusa e irreversible provocada por múltiples causas. Es una condición común que ocurre en todas las latitudes y grupos de población, es más común después de la mediana edad y es predominantemente masculina. La cirrosis es uno de los principales problemas de salud pública y una causa importante de morbilidad y mortalidad en todo el mundo. Se estima que el 57% de las cirrosis y el 78% de los cánceres primarios de hígado son causados por la infección por el virus de la hepatitis B o C. A nivel mundial, las principales causas de cirrosis son el consumo crónico de alcohol y las enfermedades virales crónicas. Las causas menos comunes incluyen enfermedad hepática autoinmune, enfermedad metabólica y enfermedad del hígado graso no alcohólico. Las complicaciones de la cirrosis son un problema grave que puede causar discapacidad y muerte en las personas. Se reporta un hombre de 15 años que refiere dolor abdominal tipo cólico, difuso y moderado, asociado con dos episodios de náuseas y regurgitación aproximadamente 24 horas después de una comida no irradiada. También informó de un aumento incalculable. Fue tratado con medicamentos no especificados, pero sus síntomas persistieron por lo que acudió a urgencias.
- Published
- 2024
29. Real-life experience of hepatitis C treatment in a Spanish prison.
- Author
-
Tejera-Pérez, Rosa Juana, Iglesias-Gómez, Alicia, Oliva-Oliva, Antonia, Rodríguez-Alonso, Beatriz, Alonso-Sardón, Montserrat, Sánchez Ledesma, María, López-Bernus, Amparo, Carbonell-Muñoz, Cristina, Pendones Ulerio, Josué, Muñoz-Bellido, Juan Luis, and Belhassen-García, Moncef
- Subjects
HEPATITIS C virus ,CIRRHOSIS of the liver ,DISEASE eradication ,PRISONERS ,LIVER diseases - Abstract
Copyright of Revista Española de Quimioterapia is the property of Sociedad Espanola de Quimioterapia and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2022
- Full Text
- View/download PDF
30. Comportamiento de las enfermedades hepáticas en una cohorte de pacientes colombianos con COVID 19
- Author
-
Santiago Sánchez Pardo, Nathaly Garzón Orjuela, John Edison Prieto Ortíz, Robin Germán Prieto Ortíz, and Javier H. Eslava Schmalbach
- Subjects
Cirrosis Hepática ,Mortalidad ,Hígado graso ,Virus del SARS ,Diseases of the digestive system. Gastroenterology ,RC799-869 - Abstract
Introducción: la infección por coronavirus del síndrome respiratorio agudo grave de tipo 2 (SARS-CoV-2) concentra la mayor atención en el momento. En el hígado es frecuente la elevación asintomática de transaminasas y la afectación hepática varía del 14 % al 78 %. La evaluación de las comorbilidades hepáticas es escasa, con prevalencias que oscilan entre el 2 % y el 11 %. Objetivo: describir el comportamiento de una cohorte de pacientes con enfermedades hepáticas que presentaron el coronavirus de 2019 (COVID-19). Materiales y métodos: estudio observacional retrospectivo que analizó el comportamiento de una cohorte de pacientes con hepatopatías que enfermaron por COVID-19. Resultados: 543 pacientes padecieron por COVID-19, de los cuales 300 fueron mujeres (55,3 %). La mediana de edad al diagnóstico de la enfermedad hepática fue de 52 años. Las principales causas de las hepatopatías fueron esteatohepatitis no alcohólica (49,5 %), enfermedad colestásica (7,7 %), virus de la hepatitis C y B (6,3 %). La alanina-aminotransferasa (ALT) presentó una mediana de 52 U/L (rango intercuartílico [RIC]: 30-98) y aspartato-aminotransferasa (AST) 32 U/L (RIC: 23-62). La mortalidad por la infección viral fue del 5,7 % con una tasa de incidencia de 2,9 (intervalo de confianza [IC] 95 %: 2-4,2). Conclusiones: es un estudio de carácter retrospectivo; sin embargo, hasta la elaboración del manuscrito es la primera cohorte en Colombia en describir el comportamiento de las enfermedades hepáticas en pacientes que enferman de COVID-19. No se encontraron diferencias estadísticamente significativas entre las causas de hepatopatía que confieran un mayor riesgo de mortalidad; sin embargo, tener una descompensación de cirrosis es la única condición que tiene una relación con la mortalidad.
- Published
- 2022
- Full Text
- View/download PDF
31. La esteatohepatitis no alcohólica: una causa emergente de cirrosis en Colombia
- Author
-
Juan David Vélez Aguirre, Lourdes Helene Lepesqueur Guillén, and Ismael de Jesús Yepes Barreto
- Subjects
Enfermedad del Hígado Graso no Alcohólico ,Cirrosis Hepática ,Síndrome Metabólico ,Diseases of the digestive system. Gastroenterology ,RC799-869 - Abstract
Introducción: la cirrosis hepática es una importante causa de morbimortalidad en América Latina; el incremento de la prevalencia del síndrome metabólico en nuestra población podría estar cambiando el perfil epidemiológico de los pacientes con enfermedad hepática crónica avanzada. Objetivos: caracterizar un grupo de pacientes con cirrosis hepática y determinar la contribución de la esteatohepatitis no alcohólica (NASH) como factor etiológico de esta población en la ciudad de Cartagena de Indias, Colombia, en un centro de atención ambulatoria de hepatología. Métodos: estudio retrospectivo, transversal, analítico. Se incluyeron todos los pacientes que acudieron al seguimiento de hepatología con diagnóstico de cirrosis hepática que se encontraban en el protocolo de seguimiento semestral que incluía el cribado de hepatocarcinoma y várices esofágicas. Resultados: se incluyeron 346 pacientes. La mayoría fueron mujeres (54,3 %). La primera y segunda causa de cirrosis fue la criptogénica (35 %) y la NASH (30,9 %), respectivamente; seguidas de las hepatitis virales (17 %) y enfermedades autoinmunes (9 %). De estos pacientes, el 87,4 % se encontraba dentro de las categorías A y B de la escala pronóstica de Child-Turcotte-Pugh, y solo el 12,5 % (33 pacientes) en estadio C. El 60 % había presentado al menos una descompensación clínica, 38 % tenía antecedentes de hemorragia por várices y 4 %, diagnóstico de hepatocarcinoma. El 80,6 % de los pacientes con cirrosis NASH era diabético y el 46,7 % tenía exceso de peso. Conclusión: La cirrosis NASH es una causa emergente de enfermedad hepática crónica avanzada en Colombia.
- Published
- 2022
- Full Text
- View/download PDF
32. Comportamiento de las enfermedades hepáticas en una cohorte de p acientes colombianos con COVID-19.
- Author
-
Sánchez-Pardo, Santiago, Garzón-Orjuela, Nathaly, Germán Prieto-Ortiz, Robin, Eslava-Schmalbach, Javier, and Edison Prieto-Ortiz, Jhon
- Abstract
Introduction: Severe acute respiratory syndrome type 2 coronavirus infection (SARS-CoV-2) is receiving the most attention now. The asymptomatic elevation of transaminases is typical in the liver, and liver involvement varies from 14 % to 78 %. The assessment of liver comorbidities is scarce, with prevalence ranging between 2 % and 11 %. Aim: To describe the behavior of a cohort of patients with liver diseases who fell ill with corona- virus disease 2019 (COVID-19). Materials and methods: This retrospective observational study analyzed the behavior of a cohort of patients with liver diseases who fell ill with COVID-19. Results: 543 patients became ill with COVID-19, of which 300 were women (55.3 %). The median age at diagnosis of liver disease was 52 years. The leading causes of liver disease were nonalcoholic steatohepatitis (49.5 %), cholestatic disease (7.7 %), and hepatitis C and B viruses (6.3 %). Alanine aminotransferase (ALT) had a median of 52 U/L (in- terquartile range [IQR]: 30–98) and aspartate aminotransferase (AST) 32 U/L (IQR: 23–62). Mortality due to viral infection was 5.7 %, with an incidence rate of 2.9 (95 % confidence interval [CI]: 2–4.2). Conclusions: It is a retrospective study but, until the preparation of the manuscript, it had been the first cohort in Colombia to describe the behavior of liver diseases in patients who become ill with COVID-19. No statistically significant differences were found between the causes of liver disease that confer a higher risk of mortality; however, having decompensated cirrhosis is the only condition related to mortality. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
33. La esteatohepatitis no alcohólica: una causa emergente de cirrosis en Colombia.
- Author
-
Vélez-Aguirre, Juan David, Lepesqueur-Guillén, Lourdes, and Yepes-Barreto, Ismael
- Abstract
Introduction: Cirrhosis of the liver is a significant cause of morbidity and mortality in Latin America; the increased prevalence of metabolic syndrome in our population could be changing the epidemiological profile of patients with advanced chronic liver disease. Aim: To characterize a group of patients with cirrhosis of the liver at an outpatient hepatology care center in Cartagena de Indias, Colombia, and determine the contribution of nonalcoholic steatohepatitis (NASH) as an etiological factor in this population. Materials and methods: Retrospective, cross-sectional, analytical study. All patients who attended the hepatology follow-up with a diagnosis of cirrhosis of the liver were in the six-monthly follow-up protocol that included screening for hepa- tocellular carcinoma (HCC) and esophageal varices. Results: 346 patients were included, most were women (54.3 %). The first and second causes of cirrhosis were cryptogenic (35 %) and NASH (30.9 %), respectively, followed by viral hepatitis (17 %) and autoimmune diseases (9 %). Of these patients, 87.4 % were within ca- tegories A and B of the Child-Turcotte-Pugh score, and only 12.5 % (33 patients) were in stage C. Also, 60 % had at least one clinical decompensation, 38 % a history of variceal hemorrhage, and 4 % a diagnosis of HCC; 80.6 % of patients with NASH cirrhosis had diabetes, and 46.7 % were overweight. Conclusion: NASH cirrhosis is an emerging cause of advanced chronic liver disease in Colombia. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
34. Influence of socioeconomic and cultural factors in the etiology of cirrhosis of the liver
- Author
-
F. Roesch-Dietlen, M. González-Santes, Y.J. Sánchez-Maza, F. Díaz-Roesch, A.D. Cano-Contreras, M. Amieva-Balmori, K.R. García-Zermeño, L. Salgado-Vergara, J.M. Remes-Troche, and S. Ortigoza-Gutiérrez
- Subjects
Cirrosis hepática ,Etiología ,Fctores socioeconómicos y culturales ,Diseases of the digestive system. Gastroenterology ,RC799-869 - Abstract
Introduction and aim: Cirrhosis of the liver is a serious public health problem worldwide, with regional variations determined by cultural factors and economic development. Aim: To know the characteristics of the social, cultural, and economic factors of the patients with cirrhosis of the liver in Veracruz. Materials and methods: A multicenter, retrolective, relational research study was conducted on patients with cirrhosis of the liver at 5 healthcare institutions in Veracruz. The variables analyzed were etiology, age, sex, civil status, educational level, occupation, and income. Descriptive and inferential statistics were utilized, and statistical significance was set at a p
- Published
- 2021
- Full Text
- View/download PDF
35. Ligature of varicose veins by videoendoscopy in patients with upper digestive bleeding
- Author
-
María Elena Pérez Artímez, Jesús Fernández Duharte, Vladimir Brice Abreu, Sixto Alain Dinza Cabrejas, and Gema de las Mercedes Colas Prevost
- Subjects
varices esofágicas y gástricas ,hipertensión portal ,cirrosis hepática ,hematemesis ,endoscopia del sistema digestivo ,ligadura. ,Medicine (General) ,R5-920 ,Internal medicine ,RC31-1245 - Abstract
Introduction: The esophageal varicose veins are vascular channels that unite the portal venous and systemic circulation. They are formed as consequence of the portal hypertension, predominantly in the submucosa of the inferior section of the esophagus. Objective: To characterize patients with break of esophageal varicose veins according to main clinical epidemiological and therapeutic-endoscopic variables. Methods: An observational, descriptive and longitudinal study of 20 patients with upper digestive bleeding due to break of esophageal varicose veins was carried out, they received endoscopic treatment with banding in the Gastroenterology Service of Dr. Juan Bruno Zayas Alfonso Teaching General Hospital in Santiago de Cuba, from November, 2016 to February,2018. In the statistical analysis the percentage was used as summary measure and the chi-square test was applied to identify the existence of some significant association among variables. Results: There was a prevalence of the male sex (80.0 %) and the 51 to 60 age group (40.0 %). Most of the patients presented liver cirrhosis (60.0 %) as cause of the portal hypertension and hematemesis (50.0 %) as form of upper digestive bleeding; also, the great size of the esophageal varicose veins was the main risk factor associated with the break (70.0 %) and, after the implementation of the endoscopic treatment, there was no second bleeding in almost all the patients (95.0 %). Conclusions: The application of this therapeutic procedure was satisfactory and it didn't cause any complication.
- Published
- 2020
36. Sobrevida en pacientes con cirrosis de acuerdo con su etiología. Cohorte retrospectiva
- Author
-
Jhon Edison Prieto-Ortiz, Nathaly Garzón Orjuela, Santiago Sánchez-Pardo, Robin Germán Prieto-Ortíz, and Javier Eslava Schmalbach
- Subjects
cirrosis hepática ,sobrevida ,hígado graso ,enfermedad del hígado graso no alcohólico ,Diseases of the digestive system. Gastroenterology ,RC799-869 - Abstract
Introducción: la cirrosis es el estadio final de enfermedades hepáticas crónicamente progresivas de diferentes etiologías. Es una enfermedad frecuente, con una prevalencia variable en cada país. Su pico de incidencia se presenta entre los 40 y 50 años, predominantemente en hombres. Objetivos: comparar una cohorte de pacientes con diagnóstico de cirrosis, evaluar sus complicaciones y sobrevida de acuerdo con su etiología, describir los aspectos clínicos y de laboratorio, y determinar el papel del hígado graso. Materiales y métodos: se realizó un estudio de cohorte retrospectiva, en donde se incluyeron pacientes que asistieron a consulta especializada de hepatología en el centro de enfermedades hepáticas y digestivas (CEHYD), en la ciudad de Bogotá, durante enero de 2010 y junio de 2019. Resultados: se revisaron un total de 1200 historias clínicas (56,8 % mujeres). No se evidenció diferencias estadísticamente significativas en las medianas de sobrevida entre los grupos por etiologías, sexo, presencia o no de complicaciones, o Child. Se evidenció que entre mayor edad en el diagnóstico de cirrosis, el riesgo de muerte es mayor; HR 1,04 (IC 95 % 1,02-1,075). Por cada mes que aumenta el seguimiento se reduce el riesgo de muerte en 90 %; HR 0,1 (IC 95 % 0,03-0,29). Por cada mes que aumenta el seguimiento de las complicaciones se reduce el riesgo de muerte en 2 %; HR 0,98 (IC 95 % 0,97-0,99). Conclusiones: La sobrevida por etiología fue similar en los diferentes grupos. La esteatohepatitis no alcohólica (NASH) fue la principal causa de cirrosis en esta cohorte. Se deben orientar esfuerzos a su diagnóstico y manejo en fases tempranas.
- Published
- 2022
- Full Text
- View/download PDF
37. Síndrome hepatorrenal: revisión de la literatura
- Author
-
Annia Cristina Amador, Ledmar Jovanny Vargas Rodríguez, Geovanny Hernández, Diana Paola Sanabria Aguilar, Paola Andrea Bolívar Córdoba, Jeinny Lucero Ruiz Muñoz, Mónica Dayana Romero Cely, and Nahala Fahed Aborashed Amador
- Subjects
síndrome hepatorrenal ,cirrosis hepática ,insuficiencia renal ,diagnóstico ,Internal medicine ,RC31-1245 ,Diseases of the genitourinary system. Urology ,RC870-923 - Abstract
Contexto: el síndrome hepatorrenal es una disfunción renal que ocurre en pacientes con enfermedad hepática crónica como cirrosis hepática o enfermedad hepática aguda, caracterizada porla activación de mecanismos reguladores que conducen a la disminución de la tasa de filtrado glomerular. Clínicamente, el síndrome hepatorrenal se divide en dos tipos: el tipo 1 se caracteriza por una pérdida rápida y progresiva de la función renal, mientras que el tipo 2 se caracteriza por ser de progresión lenta y de mejor pronóstico. Objetivo: analizar la historia natural de la enfermedad que presentan los pacientes que desarrollan síndrome hepatorrenal. Metodología: se realizó una revisión de la literatura científica de manuscritos publicados sobre síndrome hepatorrenal, para evaluar la historia natural de esta patología. Resultados: no existen hallazgos clínicos específicos, sin embargo, sus manifestaciones clínicas reflejan la enfermedad hepática avanzada subyacente, la insuficiencia renal y las anomalías circulatorias presentes. Conclusiones: la opción terapéutica más adecuada es el trasplante hepático, pero no todos los pacientes pueden recibirlo, mientras se accede a dicho manejo una opción es el tratamiento medicamentoso con vasoconstrictores y albúmina.
- Published
- 2022
- Full Text
- View/download PDF
38. Insuficiencia renal en cirrosis: revisión de laliteratura
- Author
-
Amilkar José Almanza Hurtado, Tomás Rodríguez Yánez, María Cristina Martínez-Ávila, and Pedro Imbeth Acosta
- Subjects
insuficiencia renal aguda ,creatinina ,cirrosis hepática ,síndrome hepatorrenal ,Internal medicine ,RC31-1245 ,Diseases of the genitourinary system. Urology ,RC870-923 - Abstract
Contexto: en el curso de la enfermedad del paciente cirrótico, la insuficiencia renal es un eventode mal pronóstico. Objetivo: identificar en estos pacientes los factores de riesgo de IRA, tales como: presencia deprocesos infecciosos, hipovolemia inducida por hemorragia, pérdidas gastrointestinales o renalesy agentes nefrotóxicos, ya que conocer de su aparición es primordial para dar comienzo a lasmedidas terapéuticas y las acciones profilácticas. Metodología: se realizó una búsqueda bibliográfica en las bases de datos PubMed, EMBASE,Scopus y Google académico, usando los términos MeSH como insuficiencia renal aguda, creatinina, cirrosis hepática, síndrome hepatorenal. Se obtuvieron resultados entre artículos originales, metaanálisis, reportes de casos, series de casos y revisiones de la literatura, y se escogieron 16 documentos para la elaboración de esta revisión. Resultados: los nuevos criterios definidos por el Club Internacional de Ascitis (AKI-IAC), loscuales eliminan el gasto urinario, se determinan por un aumento de la creatinina sérica?0,3mg/dL en menos de 48 horas y, mejoran el pronóstico, permitiendo realizar intervenciones opor-tunas. Conclusiones: la creatinina sigue siendo el biomarcador más utilizado en insuficiencia renalaguda (IRA), incluso en pacientes cirróticos, a pesar de sus múltiples limitaciones. Un criterio dinámico modificado a partir de los criterios de AKIN, se convierte en el patrón de oro para eldiagnóstico de IRA en cirrosis.
- Published
- 2022
- Full Text
- View/download PDF
39. Sobrevida en pacientes con cirrosis de acuerdo con su etiología. Cohorte retrospectiva.
- Author
-
Prieto-Ortiz, Jhon Edison, Garzón-Orjuela, Nathaly, Sánchez-Pardo, Santiago, Prieto-Ortiz, Robin German, and Eslava-Schmalbach, Javier
- Abstract
Introduction: Cirrhosis is the final stage of chronically progressive liver diseases of various etiologies. It is a common disease, with a variable prevalence in each country. Its peak incidence occurs between 40 and 50 years of age, predominantly in men. Aims: To compare a cohort of patients diagnosed with cirrhosis, evaluate their complications and survival according to etiology, describe clinical and laboratory aspects, and determine the role of a fatty liver. Materials and methods: A retrospective cohort study was carried out with patients who held a specialized hepatology consultation in the center of liver and digestive diseases (CEHYD) in Bogotá, Colombia, between January 2010 and June 2019. Results: We reviewed a total of 1,200 medical records (56.8 % women). There were no statistically significant differences in median survival between groups by etiology, sex, presence or absence of complications, or Child. We noted that the older the age at the diagnosis of cirrhosis, the higher the risk of death; HR 1.04 (95 % CI 1.02-1.075). For each month that follow-up increases, the risk of death decreases by 90 %; HR 0.1 (95 % CI 0.03-0.29). For each month that the follow-up of complications increases, the risk of death is reduced by 2 %; HR 0.98 (95 % CI 0.97-0.99). Conclusions: Survival by etiology was similar in the different groups. Nonalcoholic steatohepatitis (NASH) was the leading cause of cirrhosis in this cohort. Efforts should focus on its diagnosis and management in the early stages. [ABSTRACT FROM AUTHOR]
- Published
- 2022
- Full Text
- View/download PDF
40. MÉTODOS DE EVALUACIÓN MUSCULAR PARA EL DIAGNÓSTICO DE SARCOPENIA EN PACIENTES CIRRÓTICOS.
- Author
-
CHAPELA, SEBASTIÁN P., PEGORARO, PAOLA M., AQUINO, MARIEL, MANGIAROTTI, DANIELA, CORONIL, JULIO, and AREAS, NATALIA
- Abstract
Copyright of Medicina (Buenos Aires) is the property of Medicina (Buenos Aires) and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2021
41. Adaptation and validation of an abbreviated version of the SIPAT integrated psychosocial risk scale in patients with liver cirrhosis candidates for liver transplantation (SIPAT-11).
- Author
-
García Morales N, Gutiérrez Morato S, Castillo Cejas C, Fernández de la Varga M, Menéndez Rodríguez M, Aguilera V, Benlloch S, Menéndez Rodríguez L, Seoane Pillado T, and Cubiella J
- Abstract
Introduction: Patients with liver cirrhosis who are candidates for liver transplantation must be evaluated both clinically and socially in order to obtain the optimal outcomes and avoid futile therapeutic measures. For the evaluation of the social aspects in these patients, no validated scale in Spanish is available. The SIPAT (Stanford Integrated Psychosocial Assessment for Transplantation) scale is an instrument that measures the social, family and psychological aspects in candidates for solid organ transplantation. The objective of this study is to adapt and validate an abbreviated version of the SIPAT scale in Spanish for patients with liver cirrhosis., Material and Methods: Prospective observational study carried out in the Hepatology Unit of the La Fe Unversity Hospital in Valencia, by questionnaire validation methodology. To analyze the reliability of the questionnaire, the internal consistency of all variables was calculated, for variability an exploratory factor analysis, and for stability the test-retest test was carried out., Results: 96 patients who were admitted for decompensated cirrhosis to the Hepatology Unit of the La Fe Hospital in Valencia between November 1, 2017 and January 31, 2017 were selected. 84% were men, the mean age was 60.01 (SD 10.12) years. In 73.2% of those admitted, the etiology of cirrhosis was alcoholic. 14.4% had a Child's stage A, 57.7% B and 27.8% C. The internal consistency of all variables reached a Cronbach's Alpha of 0.766. In the exploratory factor analysis, 6 dimensions of the questionnaire were identified that explain 84.27% of the total variability. To see the stability of the instrument, the measurement was repeated at 2 and 6 months of follow-up, obtaining in the test-retest a kappa agreement of 0.612 and 0.565 respectively., Conclusion: The SIPAT-11 questionnaire has good psychometric characteristics in cirrhotic patients who are candidates for liver transplantation. It is easy to complete and can be administered by professionals who are not specialists in the area of Mental Health., (Copyright © 2024 Elsevier España, S.L.U. All rights reserved.)
- Published
- 2024
- Full Text
- View/download PDF
42. Clinical profile of Spanish hepatitisC virus-infected treatment-naïve patients with compensated cirrhosis in the CREST study.
- Author
-
Jorquera F, Ledesma F, Ahumada A, Manzano ML, Castiella A, Lorente S, Miquel M, Mariño Z, Castellote J, Sanz E, and Uriz J
- Subjects
- Humans, Male, Spain epidemiology, Middle Aged, Female, Hepatitis C, Chronic drug therapy, Hepatitis C, Chronic complications, Aged, Sulfonamides therapeutic use, Benzimidazoles therapeutic use, Adult, Leucine analogs & derivatives, Leucine therapeutic use, Pyrrolidines therapeutic use, Liver Cirrhosis, Antiviral Agents therapeutic use
- Abstract
Background and Aim of the Study: There are still patients with hepatitisC in Spain who have yet to be diagnosed, but their clinical profile is unclear. In 2021, 21.93% of patients diagnosed had cirrhosis and were mostly treatment-naïve., Methods: This sub-analysis describes the clinical profile of the 60Spanish treatment-naïve patients with compensated cirrhosis who were included in the CREST study., Major Results: Sixty percent of patients were male, median age 56years, and 33% had a history of drug use. Almost three-quarters (71.3%) had more than one comorbidity and 78.3% took concomitant medication. At treatment initiation, median platelet count was 139×10
3 /μL and FibroScan® 17kPa. No virological failure was observed and no patient discontinued treatment due to adverse events. No clinically significant changes were noted during or after treatment in the median platelet, albumin, bilirubin, and transaminase levels., Conclusions: Treatment with glecaprevir/pibrentasvir for 8weeks in this cohort of treatment-naïve patients with compensated cirrhosis in Spain was safe and effective. This information reinforces the use of this short antiviral regimen even when there is compensated cirrhosis, simplifying the approach to hepatitisC among those patients still to be diagnosed and treated in Spain., (Copyright © 2024 Elsevier España, S.L.U. All rights reserved.)- Published
- 2024
- Full Text
- View/download PDF
43. Neumonía por coinfección de Aspergillus fumigatus y Pneumocystis jirovecii en un paciente no VIH: Reporte de caso.
- Author
-
Martínez Montalvo, Carlos Mauricio, Antonio Perez, Manuel, Cynthia Fuentes-Lacouture, María, Bravo Mena, Karime, Leal Bernal, Sofía Fernanda, Magdalena Velasco, Yulieth, Charria Caicedo, Melissa, and Estrada Serrano, Natalia
- Abstract
Copyright of Acta Médica Peruana is the property of Colegio Medico del Peru and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2021
- Full Text
- View/download PDF
44. Epidemiological and clinical characteristics of patients with liver cirrhosis
- Author
-
Ludmila Martínez Leyva, Amada Belquis Palomino Besada, Evelyn Quesada Meneses, Juan Carlos Oliva Rey, Alicia Yanes Cicard, and Yesael Descalzo García
- Subjects
cirrosis hepática ,hepatitis b ,hepatitis c ,hepatitis autoinmune ,cirrosis biliar primaria ,colangitis esclerosante primaria. ,Medicine ,Medicine (General) ,R5-920 - Abstract
Introduction: Liver cirrhosis is the end stage of many liver diseases. Objective: To determine the epidemiological and clinical characteristics of patients with liver cirrhosis. Results: There were 19 patients (33.3%) in the age group between 60 and 69 years; 31 (54.4%) women and 26 (45.6%) men. Hepatitis C virus was found in 21 patients (36.8%). 96.4% of the patients were diagnosed by abdominal ultrasound; 12 (21.1%) presented ascites and 38 (66.6%) endoscopic manifestations of portal hypertension. In D'Amico stage 4 there were 20 (35 %) patients and 26 (45.6%) in Child-Pugh A stage; 24 (42.1%) in Child-Pugh B and 7 (12.3%) in Child-Pugh C. Conclusions: Liver cirrhosis predominates in the seventh decade of life, in females. Abdominal ultrasound prevails as a diagnostic mode. The most common causes are hepatitis C virus and alcoholism. Ascites is the most common complication. Most patients present with signs of portal hypertension. Uncompensated forms of the disease predominate.
- Published
- 2021
45. Tumores Primarios Malignos del Hígado. Estudio de 18 Casos y Revisión de la Bibliografía
- Author
-
Raúl Gutiérrez Cabarcas, Hernán Olarte, and Elvira Castro de Pabón
- Subjects
Cánccr del hígado ,Cirrosis hepática ,Hepatectomía ,Quimioterapia ,Radioterapia ,Surgery ,RD1-811 - Abstract
Se presentan y analizan 18 casos de tumores primarios malignos del hígado. recopilados durante 40 años en el Instituto Nacional de Cancerología, con una incidencia en las autopsias durante 20 años, del 0.41 %. La asociación con la cirrosis hepática alcanza el 22.2%. El 50% de los casos se observaron entre la 5 Q y la 1" décadas de la vida. El tumor más frecuentemente observado fue el hepatoma o Ca. hepatocelular (66.6%); la discusión se centra primordialmente en este tipo de tumor. El promedio de supervivencia en los casos sometidos a tratamiento de quimioterapia y radioterapia, fue de 8 meses. Los datos obtenidos en nuestro estudio, no difieren mayormente de los informados en la literatura médica. Se hace énfasis en los factores etiopatogénicos, medios diagnósticos, criterios pronósticos y de tratamiento oportuno y adecuado.
- Published
- 2021
46. Factores asociados a la mortalidad en pacientes cirróticos
- Author
-
Maricarmen Viera Santillán, Luis Vasquez Elera, Christopher Valdiviezo Morales, Raisa Martinez Rivera, and Mario Valladares Garrido
- Subjects
cirrosis ,cirrosis hepática ,mortalidad. ,Medicine ,Medicine (General) ,R5-920 - Abstract
Introducción: La cirrosis hepática representa en Perú el 9,1 % de las causas de mortalidad. Existe poca evidencia sobre la influencia de variables epidemiológicas y clínicas en la mortalidad de pacientes con cirrosis hepática en Latinoamérica, en especial en países en vías de desarrollo, como Perú. Objetivo: Identificar los factores asociados a la mortalidad en pacientes cirróticos. Métodos: Estudio trasversal en pacientes cirróticos atendidos en el Hospital "Cayetano Heredia", de Piura, Perú, en el año 2017. La variable dependiente fue la mortalidad hospitalaria y las variables independientes fueron las características epidemiológicas, clínicas y de laboratorio. Se utilizó la prueba exacta de Fisher y la prueba de t para estimar los factores asociados a la mortalidad. Resultados: De 52 pacientes, la frecuencia de mortalidad debido a cirrosis fue de 35,4 %. Tener ascitis moderada (p = 0,004), grado de encefalopatía (p = 0,001), leucocitosis (p = 0,004), enfermedad descompensada según índice de Child Pugh (p = 0,023), índice de Meld entre 30-39 puntos (p < 0,001) y niveles de creatinina (p = 0,009) resultaron asociados a una mayor frecuencia de mortalidad. Conclusión: La presencia de ascitis moderada, grado de encefalopatía, leucocitosis, enfermedad descompensada según índice de Child Pugh, índice de Meld entre 30-39 y los niveles de creatinina, están asociados a la mortalidad en pacientes cirróticos.
- Published
- 2021
47. Hemoperitoneum secondary to rupture of hepatocellular carcinoma
- Author
-
Yeney Espinosa Rodríguez, Josué Fuentes Rojas, Rene Rafael Bonachea Peña, and Julio Roberto Betancourt Cervantes
- Subjects
carcinoma hepatocelular ,cirrosis hepática ,hemoperitoneo. ,Medicine ,Medicine (General) ,R5-920 - Abstract
Introduction: Hepatocellular carcinoma is a hypervascular tumor made up of abnormal blood vessels. It is the most frequent form of primary liver cancer. About 90 % of these tumors develop over a previous liver disease. An increase in vascular load due to portal hypertension leads to bleeding. Objective: To present a patient who underwent emergency exploratory laparotomy due to large hemoperitoneum secondary to an intratumoral rupture of a cirrhotic liver. Clinical case: A 66-year-old male patient with a pathological history of type 2 diabetes mellitus, benign prostatic hyperplasia, chronic alcoholism and liver cirrhosis. He came to emergencydue to diffuse abdominal pain, as well as signs of acute hypovolemia. An emergency laparotomy was performed, confirming a large hemoperitoneum secondary to an intratumoral rupture. Blood content aspiration, electrocoagulation and compression by packing were performed, managing to control bleeding. He had a torpid evolution, dying 24 hours after the laparotomy. Conclusions: Hemoperitoneum secondary to rupture of a hepatocellular carcinoma is a rare, but fatal complication; therefore, its study is necessary to achieve a timely diagnosis and treatment.
- Published
- 2021
48. Métodos diagnósticos en hipertensión portal
- Author
-
Octavio Muñoz Maya, José Ferrusquía-Acosta, Laura María Serna-Patiño, and Andres Cárdenas
- Subjects
Hipertensión portal ,Sistema porta ,Cirrosis hepática ,Diseases of the digestive system. Gastroenterology ,RC799-869 - Abstract
La hipertensión portal es un síndrome caracterizado por el incremento en el gradiente de presión portal, definido por la diferencia entre la presión de la porta y la vena cava inferior. Esta presión depende del flujo venoso y la resistencia vascular. En los pacientes cirróticos estas dos variables están alteradas de manera suprafisiológica, inicialmente por la lesión estructural dependiente de fibrosis y los nódulos de regeneración y posteriormente por cambios dinámicos vasculares que causan vasoconstricción intrahepática y vasodilatación esplácnica, lo cual explica las manifestaciones sistémicas de la cirrosis. La importancia de la hipertensión portal radica en la frecuencia y severidad de las complicaciones asociadas, especialmente la hemorragia variceal y otras como ascitis, peritonitis bacteriana espontanea, síndrome hepatorrenal y encefalopatía hepática. El objetivo de este artículo es realizar una revisión actualizada sobre el uso de las pruebas diagnósticas invasivas y no invasivas disponibles para el estudio de la hipertensión portal y su aplicación en la práctica clínica.
- Published
- 2021
- Full Text
- View/download PDF
49. Healthcare-associated infections in hospitalized cirrhotic patients
- Author
-
Yoel Mario Ricardo-Serrano, Anaisa Rodríguez-Pereira, Jorge Omar Cabrera-Lavernia, Gloria Mabel Martí-Garcés, and Maythe Pelaez-Llorente
- Subjects
cirrosis hepática ,infecciones ,infecciones asociadas al cuidado sanitario ,Medicine - Abstract
Introduction: liver cirrhosis has been confirmed as one of the most common diseases in Cuba. Infection and decompensated cirrhosis constitute the cause of hospitalization. Objective: to identify the most frequent health care-associated diseases in hospitalized cirrhotic patients. Method: a cohort study involving 90 hospitalized patients with cirrhosis was conducted at the Hospital General Provincial “Carlos Manuel de Céspedes” in Granma, from January 2017 through September 2020. The total patients underwent study were over 18 years old and both sex. Data were collected from patients´ hospitalization history. Chi-square test was utilized for statistical analysis and to measure its power (the relative risk), a P-value less than 0.05 was used. Results: most patients were male, decompensated with Child-Pugh class B. All hospitalized patients who underwent health care such as bladder catheter placement, central and peripheral venous approach, as well as endotracheal intubation, alcohol was considered the major etiological factor cause of cirrhosis. The main healthcare-associated infections observed in these patients were phlebitis, bacteremia, urinary tract infection and pneumonia. Conclusions: the healthcare-associated infections in order of frequency were phlebitis, bacteremia, pyelonephritis, pneumonia and cystitis.
- Published
- 2021
50. Diagnostic performance of platelet count/spleen diameter ratio to detect esophageal varices in patients with cirrhosis.
- Author
-
David Martínez-Marín, Julián, Marrugo-Padilla, Katherine, and Alonso Garzón-Olarte, Martín
- Subjects
PLATELET count ,ESOPHAGEAL varices ,CIRRHOSIS of the liver ,PERSONAL computer performance ,AUTOIMMUNE hepatitis ,SPLEEN - Abstract
Copyright of Revista Facultad de Medicina de la Universidad Nacional de Colombia is the property of Universidad Nacional de Colombia and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)
- Published
- 2021
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.